House Ways and Means Committee Chairman Smith: As Democrats Celebrate New Drug Price-Setting Scheme, Americans Are Already Paying Price in Higher Health Care Costs
August 16, 2024
August 16, 2024
WASHINGTON, Aug. 16 -- Rep. Jason Smith, R-Missouri, chairman of the House Ways and Means Committee, issued the following news release on Aug. 15, 2024:
Today, the Biden-Harris Administration announced ten medications that will be subject to the Democrats' brand of Washington-knows-best price controls under which patients will see increased costs to get the drugs they rely on and research and development will be slowed for new cures coming to market. The Democrats' so-called Inflati . . .
Today, the Biden-Harris Administration announced ten medications that will be subject to the Democrats' brand of Washington-knows-best price controls under which patients will see increased costs to get the drugs they rely on and research and development will be slowed for new cures coming to market. The Democrats' so-called Inflati . . .